Toshiaki Yoshimoto

Toshiaki Yoshimoto

Auto-generated profile, based on publicly available information

Toshiaki Yoshimoto

Department of Surgery University of Tokushima Graduate School Tokushima Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2018 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
TYToshiaki Yoshimoto
Toshiaki Yoshimoto
YMYuji Morine
Yuji Morine
CTChie Takasu
Chie Takasu
RFRui Feng
Rui Feng
TITetsuya Ikemoto
Tetsuya Ikemoto
MSMitsuo Shimada
Mitsuo Shimada
Background: Light emitting‐diodes (LED) have various effects on living organisms and recent studies have shown the efficacy of visible light irradiation from LED for anticancer therapies. However, the mechanism of LED's effects on cancer cells remains unclear. The aim of the present study was to investigate the effects of LED on colon cancer cell lines and the role of photoreceptor Opsin 3 (Opn3) on LED irradiation in vitro.Methods: Human colon cancer cells (HT‐29 or HCT‐116) were seeded onto laboratory dishes and irradiated with 465‐nm LED at 30 mW/cm2 for 30 minutes. Cell Counting Kit‐8 was used to measure cell viability, and apoptosis and caspase 3/8 expression were evaluated by AnnexinV/PI and reverse transcription‐polymerase chain reaction (RT‐PCR), respectively. Autophagy and expression of LC‐3 and beclin‐1 were also evaluated by autophagy assays, RT‐PCR and Western blotting. We further tested Opn3 knockdown by Opn3 siRNA and the Gi/o G‐protein inhibitor NF023 in these assays.Results: Viability of HT‐29 and HCT‐116 cells was lower in 465‐nm LED‐irradiated cultures than in control cultures. LC‐3 and beclin‐1 expressions were significantly higher in LED‐irradiated cultures, and autophagosomes were detected in irradiated cells. The reductive effect of cancer cell viability following blue LED irradiation was reversed by Opn3 knockdown or NF023 treatment. Furthermore, increased LC‐3 and beclin‐1 expression that resulted from blue LED irradiation was suppressed by Opn3 knockdown or NF023 treatment.Conclusion: Blue LED irradiation suppressed the growth of colon cancer cells and Opn3 may play an important role as a photoreceptor.

12 February 2020 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
TYToshiaki Yoshimoto
Toshiaki Yoshimoto
KYKozo Yoshikawa
Kozo Yoshikawa
JHJun Higashijima
Jun Higashijima
TMTomohiko Miyatani
Tomohiko Miyatani
TTTakuya Tokunaga
Takuya Tokunaga
MSMitsuo Shimada
Mitsuo Shimada
Aim: The purposes of this study are to present cases of emergency surgery in which gastrointestinal perforation occurred during bevacizumab administration, consider the indications for emergency surgery, and examine the safety of scheduled surgery after a washout period for bevacizumab.Methods: (a) We retrospectively investigated seven patients who underwent emergency surgery for bevacizumab‐associated intestinal perforation. (b) We investigated 104 patients with advanced colorectal cancer treated with neoadjuvant therapy who underwent surgery from 2008 to 2018, retrospectively.Results: (a) In the seven patients undergoing emergency surgery for gastrointestinal perforation, the median bevacizumab administration and washout periods were 16 weeks and 24 days, respectively. A stoma was created in all patients except in those who were not candidates. Two patients developed postoperative abdominal abscesses, and two patients died from perioperative sepsis and gastrointestinal bleeding, respectively; both of these patients had poor performance status. (b) In patients receiving bevacizumab (n = 45) and patients treated with bevacizumab‐free regimens as neoadjuvant therapy (n = 59), 31 and 52 patients received chemoradiotherapy, respectively. We found no correlation with postoperative complications with or without bevacizumab.Conclusion: The surgical indications should be considered carefully in patients with gastrointestinal perforation secondary to bevacizumab administration. Meanwhile, after appropriate cessation time, scheduled surgery following bevacizumab administration is feasible.

1 April 2021 in Asian Journal of Endoscopic Surgery
Verified
Journal Article
Closed access
PDF file
TYToshiaki Yoshimoto
Toshiaki Yoshimoto
KYKozo Yoshikawa
Kozo Yoshikawa
TTTakuya Tokunaga
Takuya Tokunaga
MNMasaaki Nishi
Masaaki Nishi
CTChie Takasu
Chie Takasu
MSMitsuo Shimada
Mitsuo Shimada

12 September 2021 in Asian Journal of Endoscopic Surgery
Verified
Journal Article
Closed access
PDF file
SEShohei Eto
Shohei Eto
KYKozo Yoshikawa
Kozo Yoshikawa
TYToshiaki Yoshimoto
Toshiaki Yoshimoto
CTChie Takasu
Chie Takasu
HKHideya Kashihara
Hideya Kashihara
MSMitsuo Shimada
Mitsuo Shimada

18 July 2020 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
TYToshiaki Yoshimoto
Toshiaki Yoshimoto
TITetsuya Ikemoto
Tetsuya Ikemoto
YMYuji Morine
Yuji Morine
SISatoru Imura
Satoru Imura
YSYu Saito
Yu Saito
MSMitsuo Shimada
Mitsuo Shimada
Aim: Pancreatectomy causes both hyperglycemia, secondary to surgical stress, and pancreatic diabetes, which leads to difficult‐to‐control postoperative blood glucose levels. We investigated whether using an artificial pancreas perioperatively to provide appropriate blood glucose control could reduce postoperative complications following pancreatectomy.Methods: We retrospectively enrolled 52 patients who underwent pancreatectomy at Tokushima University Hospital from 2015 to 2019. The most recent 26/52 patients received perioperative blood glucose control using an artificial pancreas. Postoperative blood glucose control with manual insulin injections based on a sliding scale was performed in the earlier 26 patients (controls). We compared surgical outcomes between the artificial pancreas group and the control group.Results: There was no significant difference in patients' white blood cell or neutrophil counts, prognostic nutritional index, neutrophil‐lymphocyte ratio, and C‐reactive protein‐to‐albumin ratio on postoperative day 1; however, lymphocyte counts were higher in the artificial pancreas group. The number of serious complications of Clavien‐Dindo grade >IIIa was significantly lower in the artificial pancreas group (P < .05).Conclusions: Using an artificial pancreas for perioperative blood glucose control in patients undergoing pancreatectomy decreased the number of serious complications through proper management of blood glucose levels without hypoglycemia, and may influence peripheral lymphocytes.

12 September 2021 in Asian Journal of Endoscopic Surgery
Verified
Journal Article
Closed access
PDF file
MNMasaaki Nishi
Masaaki Nishi
MSMitsuo Shimada
Mitsuo Shimada
KYKozo Yoshikawa
Kozo Yoshikawa
TTTakuya Tokunaga
Takuya Tokunaga
HKHideya Kashihara
Hideya Kashihara
SIShoko Iwahashi
Shoko Iwahashi